UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 23, 2014

 

HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-35853	45-5210462
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

84 October Hill Road, Suite 11, Holliston, MA	01746
(Address of principal executive offices)	(Zip Code)

 

Registrant's telephone number, including area code: (774) 233-7300

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

  

Item 7.01 Regulation FD Disclosure.

  

On Tuesday, December 23, 2014, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) hosted a conference call with investors (the “Investor Call”). The Company previously filed the script for the Investor Call on a Form 8-k. The transcript for the Investor Call, which includes the script and the questions and answers that occurred on the Investor Call, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information disclosed under this Item 7.01 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

	Exhibit Number		Title
	99.1		Transcript for Harvard Apparatus Regenerative Technology, Inc.’s December 23, 2014 Investor Call.

  

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		Harvard Apparatus Regenerative Technology, INC.
		(Registrant)
December 24, 2014		/s/ Thomas McNaughton
(Date)		Thomas McNaughton Chief Financial Officer

  

 

 

INDEX TO EXHIBITS

 

Exhibit Number		Description of Exhibit
99.1		Transcript for Harvard Apparatus Regenerative Technology, Inc.’s December 23, 2014 Investor Call.